352R Target Dimenhydrinate 50 mg Tablets
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES INC | TIME CAP LABORATORIES, INC
- Effective date
- 2025-01-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 00:58:07
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Dimenhydrinate 50 mg
OTC - PURPOSE SECTION
Purpose
Antiemetic
INDICATIONS & USAGE SECTION
Uses
for prevention and treatment of these symptoms associated with motion sickness:
- nausea
- vomiting
- dizziness
WARNINGS SECTION
Warnings
Do not give to children under 2 years of age unless directed by a doctor.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- trouble urinating due to an enlarged prostate gland
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
OTC - WHEN USING SECTION
When using this product
- marked drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a doctor before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
DOSAGE & ADMINISTRATION SECTION
Directions
- to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity
- to prevent or treat motion sickness, see below:
Adults and children 12 years and over |
|
Children 6 to under 12 years |
|
Children 2 to under 6 years |
|
OTHER SAFETY INFORMATION
Other information
- SODIUM FREE
- store at room temperature 20-25ºC (68-77ºF)
- use by expiration date on package
INACTIVE INGREDIENT SECTION
Inactive ingredients
colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose anhydrous, magnesium stearate, microcrystalline cellulose, mineral oil
OTC - QUESTIONS SECTION
Questions or comments?Call 1-800-910-6874
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-354-24 | Motion Sickness Relief | 6 in 1 BLISTER PACK | TABLET | 6 | 2 | |
| 11673-354-24 | Motion Sickness Relief | 4 in 1 CARTON | TABLET | 4 | 2 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Motion Sickness Relief
- Dimenhydrinate 50 mg
- HYPROMELLOSE, UNSPECIFIED
- MICROCRYSTALLINE CELLULOSE
- SILICON DIOXIDE
- CROSCARMELLOSE SODIUM
- MAGNESIUM STEARATE
- MINERAL OIL
- ANHYDROUS LACTOSE
- DIMENHYDRINATE
- 8-CHLOROTHEOPHYLLINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11673-354 | 11673-354-24 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| DIMENHYDRINATE | JB937PER5C | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Motion Sickness Relief | DIMENHYDRINATE 50 MG | TARGET CORPORATION | 28586e9b-01e3-0b88-e063-6394a90af7e0 | 2025-01-29 | Warnings | 11673-354-24 11673-354 11673035424 2cd57ee4-448e-e087-e063-6294a90a78fa 28586e9b-01e3-0b88-e063-6394a90af7e0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
